Numico personnel
This article was originally published in The Tan Sheet
Executive Summary
Peter van Wel leaves company after serving under temporary contract as member of executive board responsible for U.S. operations, Dutch firm announces Jan. 30. Personnel change is part of Royal Numico's effort to "redefine the responsibilities of the U.S. management team" following firm's announcement it will divest Rexall Sundown (1"The Tan Sheet" Nov. 11, 2002, p. 3). Numico is looking for a successor with retail experience to focus on GNC, which was put on "probation" and could face divestiture if its financial performance does not improve. Van Well's successor also will be charged with executing the divestments...
You may also be interested in...
Numico CFO
Jean-Marc Huet's selection as CFO, member of executive board will be proposed to shareholders during May 9 meeting, Dutch firm says Feb. 13. Announcement follows same-day statement that Royal Numico and current CFO Pim Oomens "are discussing his resignation"; further details were not released. Huet most recently "had co-responsibility" for Goldman Sachs' Netherlands office. Oomens had joined Numico in 1988 and became CFO in 2001. Management change follows a series of personnel shifts as Numico evaluates its U.S. operations (1"The Tan Sheet" Feb. 3, 2003, In Brief)...
GNC On The Line: Retailer Faces “Probation” Period To Shape Up Financials
Royal Numico is giving subsidiary GNC a 12- to 18-month probationary period to ramp up its financial performance, President & CEO Jan Bennink told analysts in London Nov. 8
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.